Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (91-100 of 158) with videos related to

Pageof 16
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cellsAnnemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune CellsClaudia Wickenhauser, Daniel Bethmann, Zipei Feng, et al.
Plos One|November 15, 2017
STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2022
Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cellsSizhen Wang, Xiaohui Zhang, Xuemei Zou, et al.
Plos One|February 16, 2018
Correction: STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
The New England Journal of Medicine|June 1, 2022
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic CancerRom Leidner, Nelson Sanjuan Silva, Huayu Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cellsEdwin B Walker, Daniel Haley, William Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive SubtypesMatthew P Salomon, Xiaowen Wang, Diego M Marzese, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, ItalyMichele Maio, George Coukos, Soldano Ferrone, et al.
Journal for Immunotherapy of Cancer|December 20, 2018
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1Zhi-Fa Wen, Hongxiang Liu, Rong Gao, et al.
Pageof 16

Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cellsAnnemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune CellsClaudia Wickenhauser, Daniel Bethmann, Zipei Feng, et al.
Plos One|November 15, 2017
STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2022
Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cellsSizhen Wang, Xiaohui Zhang, Xuemei Zou, et al.
Plos One|February 16, 2018
Correction: STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
The New England Journal of Medicine|June 1, 2022
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic CancerRom Leidner, Nelson Sanjuan Silva, Huayu Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cellsEdwin B Walker, Daniel Haley, William Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive SubtypesMatthew P Salomon, Xiaowen Wang, Diego M Marzese, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, ItalyMichele Maio, George Coukos, Soldano Ferrone, et al.
Journal for Immunotherapy of Cancer|December 20, 2018
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1Zhi-Fa Wen, Hongxiang Liu, Rong Gao, et al.
Pageof 16